World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

A STUDY ON TREATMENT OUTCOMES BASED ON DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE

*Siva Krishna Ravulapalli, Pawan Kumar Thanniru, and Mahadevamma M.

ABSTRACT

Aim: The aim of this study was to study the treatment outcomes based on different stages of chronic kidney disease and to know any improvements in the kidney function by observing lab parameters using disease specific and patient specific. Methods: A Prospective and Observational study was performed on 70 patients which conducted in Medicine and Nephrology department of Sagar Multi-Speciality Hospital. Age distribution of patients studied was from age of 20-80years. Lab parameters such as Serum creatinine, BUN, Urine analysis and biomarkers assessment will be conducted centrally. An overview treatment outcomes of Ckd based on assessment of GFR rate in each stage will be estimated and submitted. Results: From the study it was observed that (71.4%) of patients have Hypertension, as risk-factor and (54.3%) of patients have Diabetes Mellitus and (10.0%) of patients have Family History. Out of 5 stages of CKD most patients are in (ESRD) Stage V (52.9%) followed by Stage IV (32.9%). The treatment was based on Sr Cr, GFR, BUN levels in our study we have observed that very less number of patients were having normal level of Serum Creatinine and it was identified that 7.1% of patients had shown good improvement at the time of discharge, and most of the patients have less than 15ml/min GFR value (52.9%) more than 90ml/min (1.4%), in our study we have observed that 45.7% of patients shown normal level of GFR at the time of discharge. Conclusion: In our study we observed that Males are more prone to chronic kidney disease than Females and mostly stage-V CKD patients were more identified than stage-IV CKD, with majority of patients at the age of 51 to 60 years. Treatment was provided in-order to minimize individual patient risk factors along with management of CKD. And hypertension is the major risk factor followed by Diabetes Mellitus.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR